Skip to content

Cerebral Blood Flow Evaluation With Trancranial Doppler After Interscalene Nerve Block

Cerebral Blood Flow Evaluation With Trancranial Doppler After Unilateral Interscalene Nerve Block: Observational Prospective Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04642612
Acronym
CBF-TCD
Enrollment
10
Registered
2020-11-24
Start date
2021-03-04
Completion date
2021-07-30
Last updated
2021-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Blood Flow, Horner Syndrome, Regional Anesthesia

Brief summary

The purpose of this study is to assess cerebral blood flow velocity (CBFV) following regional anesthesia for shoulder surgery. The results of this study will help to further understand the physiologic effect of the interscalene nerve block on cerebral blood flow.

Detailed description

Traditionally, cerebral blood flow (CBF) is believed to decline when mean arterial pressure (MAP) is below the lower limit of cerebral autoregulation. Cerebral blood flow autoregulation refers to the capacity of the central nervous system to maintain blood flow within a wide range of mean arterial blood pressure. The habitual thinking is that the brain is perfused merely dependent by the blood pressure and that above or below the limits of cerebral autoregularion CBF is pressure passive. Despite this notion, there is evidence showing that parameters other than MAP influence cerebral hemodynamics independent of cerebral autoregulation. One of the physiologic processes that contribute to CBF regulation is cardiac output (CO). However, exactly how an alteration in CO, in the face of a stable blood pressure, leads to a change in CBF is not entirely clear. One of the suggested mechanisms in play is the sympathetic nervous system (SNS)-mediated vasoconstriction of extracranial and proximal intracranial vessels. Cerebral arteries are abundantly innervated by sympathetic nerve fibers originating from the superior cervical ganglion. Studies have shown that CBF reduction is attenuated by pharmacologic blockade or extirpation of the cervical sympathetic chain. The anesthetic protocol for patients undergoing major shoulder surgery include an interscalene nerve block (ISNB) combined with general anesthesia in the sitting position. The ISNB involves injecting local anesthetic at the level of the cervical spinal roots. One of the most common side effects encountered after ISNB is Horner syndrome, which is characterized by ptosis, myosis, and enopthalmia. Horner's syndrome results from the diffusion of the local anesthetic solution to the ipsilateral sympathetic cervical chain (stellate ganglion). The presence of Horner's syndrome indicates spread of local anesthetic to the sympathetic chain. Whether this degree of sympatholytic following interscalene block is associated with an observable change in CBF is unknown. Studies in baboon have shown that cervical surgical sympathectomy maintained CBF in the face of hemorrhagic hypotension and CBF did not decrease until MAP was 35% of the baseline value. These results suggest that sympathectomy induced by the block of the sympathetic chain by the local anesthetic injected for the ISNB might alter CBF. Therefore, the aim of our study is to evaluate the effect of unilateral interscalene nerve block on CBF by measuring CBF velocity non-invasively with Transcranial doppler (TCD).

Interventions

DEVICETCD Measurement

CBFV measurements will be acquired continuously with the patient supine and the head neutral. Analysis of CBFV measurements will be undertaken at 3 timepoints: 1. Patient awake and supine in the holding area 2. After sedation 3. After interscalene nerve block

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing orthopedic surgery and with an indication for preoperative insertion of interscalene nerve block * 18-85 years old * Give consent to participate in study

Exclusion criteria

* Cannot give consent * Patients who are clinically unstable or require urgent/emergent intervention

Design outcomes

Primary

MeasureTime frameDescription
Cerebral Blood Flow Velocity before and after interscalene nerve blockbaseline, after 30 minutesThe TCD automatically measures blood flow velocity in the main cerebral arteries of the circle of Willis. We will target the MCA which is the closest to the temporal bone therefore the most easily accessible for insonation and monitoring. We will do a bilateral monitoring.

Secondary

MeasureTime frameDescription
Heart Ratebaseline, after 30 minutesWill be measured before/during/after interscalene nerve block placement
Respiratory Rate changes before and after interscalene nerve blockbaseline, after 30 minutesWill be measured before/during/after interscalene nerve block placement
EtCO2 changes before and after interscalene nerve blockbaseline, after 30 minutesWill be measured before/during/after interscalene nerve block placement
SpO2 changes before and after interscalene nerve blockbaseline, after 30 minutesWill be measured before/during/after interscalene nerve block placement
Systolic, diastolic, mean blood pressure changes before and after interscalene nerve blockbaseline, after 30 minutesWill be measured before/during/after interscalene nerve block placement
Position of the needle on the cervical trunk for interscalene nerve blockBaselineNeedle position for interscalene nerve block insertion will be assessed at the time of interscalene block placement
Volume of of local anesthetic30 minutes after the nerve blockLocal anesthetic characteristics will be collected after interscalene block placement.
Concentration of local anesthetic30 minutes after the nerve blockLocal anesthetic characteristics will be collected after interscalene block placement.
Type of local anesthetic30 minutes after the nerve blockLocal anesthetic characteristics will be collected after interscalene block placement.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026